These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 16990207)

  • 1. Influence of smoking habits and CARD15 mutations on the onset of Crohn's disease.
    de Diego C; Alcántara M; Valle J; Repiso A; Carrobles JM; Martínez-Castro P
    Scand J Gastroenterol; 2006 Oct; 41(10):1209-11. PubMed ID: 16990207
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutations in CARD15 and smoking confer susceptibility to Crohn's disease in the Danish population.
    Ernst A; Jacobsen B; Østergaard M; Okkels H; Andersen V; Dagiliene E; Pedersen IS; Thorsgaard N; Drewes AM; Krarup HB
    Scand J Gastroenterol; 2007 Dec; 42(12):1445-51. PubMed ID: 17852840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A population-based case-control study of CARD15 and other risk factors in Crohn's disease and ulcerative colitis.
    Brant SR; Wang MH; Rawsthorne P; Sargent M; Datta LW; Nouvet F; Shugart YY; Bernstein CN
    Am J Gastroenterol; 2007 Feb; 102(2):313-23. PubMed ID: 17100976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Does smoking influence the course of Crohn's disease in patients with the presence of gene NOD2/CARD15 mutation?].
    Dobrowolska-Zachwieja A; Kaczmarek M; Hoppe-Gołebiewska J; Kalak R; Słomski R; Linke K
    Pol Merkur Lekarski; 2005 May; 18(107):560-5. PubMed ID: 16161956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three common CARD15 mutations are not responsible for the pathogenesis of Crohn's disease in Iranians.
    Teimoori-Toolabi L; Vahedi H; Mollahajian H; Kamali E; Hajizadeh-Sikaroodi S; Zeinali S; Tabrizian T; Olfati G; Rashtak S; Malekzadeh F; Ghoddosi A; Malekzadeh R
    Hepatogastroenterology; 2010; 57(98):275-82. PubMed ID: 20583427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The V249I polymorphism of the CX3CR1 gene is associated with fibrostenotic disease behavior in patients with Crohn's disease.
    Sabate JM; Ameziane N; Lamoril J; Jouet P; Farmachidi JP; Soulé JC; Harnois F; Sobhani I; Jian R; Deybach JC; de Prost D; Coffin B
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):748-55. PubMed ID: 18617779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of NOD2/CARD15 mutations on Crohn's disease phenotype in an Italian population.
    Bianchi V; Maconi G; Ardizzone S; Colombo E; Ferrara E; Russo A; Tenchini ML; Porro GB
    Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):217-23. PubMed ID: 17301648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of NOD2/CARD15 mutations in Malaysian patients with Crohn's disease.
    Chua KH; Hilmi I; Ng CC; Eng TL; Palaniappan S; Lee WS; Goh KL
    J Dig Dis; 2009 May; 10(2):124-30. PubMed ID: 19426395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NOD1 gene E266K polymorphism is associated with disease susceptibility but not with disease phenotype or NOD2/CARD15 in Hungarian patients with Crohn's disease.
    Molnar T; Hofner P; Nagy F; Lakatos PL; Fischer S; Lakatos L; Kovacs A; Altorjay I; Papp M; Palatka K; Demeter P; Tulassay Z; Nyari T; Miheller P; Papp J; Mandi Y; Lonovics J;
    Dig Liver Dis; 2007 Dec; 39(12):1064-70. PubMed ID: 17964870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of CARD15 mutations and smoking in the course of Crohn's disease in a Mediterranean area.
    Renda MC; Orlando A; Civitavecchia G; Criscuoli V; Maggio A; Mocciaro F; Rossi F; Scimeca D; Modesto I; Oliva L; Cottone M
    Am J Gastroenterol; 2008 Mar; 103(3):649-55. PubMed ID: 18341489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical applications of NOD2/CARD15 mutations in Crohn's disease.
    Barreiro-de Acosta M; Peña AS
    Acta Gastroenterol Latinoam; 2007 Mar; 37(1):49-54. PubMed ID: 17486745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies.
    van der Linde K; Boor PP; Houwing-Duistermaat JJ; Crusius BJ; Wilson PJ; Kuipers EJ; de Rooij FW
    Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):449-59. PubMed ID: 17489054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulomatous rosacea and Crohn's disease in a patient homozygous for the Crohn-associated NOD2/CARD15 polymorphism R702W.
    van Steensel MA; Badeloe S; Winnepenninckx V; Vreeburg M; Steijlen PM; van Geel M
    Exp Dermatol; 2008 Dec; 17(12):1057-8. PubMed ID: 18616576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations.
    Barreiro-de Acosta M; Domínguez-Muñoz JE; Núñez-Pardo de Vera MC; Lozano-León A; Lorenzo A; Peña S
    Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):73-8. PubMed ID: 17206080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diverse effects of the CARD15 and IBD5 loci on clinical phenotype in 630 patients with Crohn's disease.
    Onnie CM; Fisher SA; Prescott NJ; Mirza MM; Green P; Sanderson J; Forbes A; Lewis CM; Mathew CG
    Eur J Gastroenterol Hepatol; 2008 Jan; 20(1):37-45. PubMed ID: 18090989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homozygosity for the CARD15 frameshift mutation 1007fs is predictive of early onset of Crohn's disease with ileal stenosis, entero-enteral fistulas, and frequent need for surgical intervention with high risk of re-stenosis.
    Seiderer J; Schnitzler F; Brand S; Staudinger T; Pfennig S; Herrmann K; Hofbauer K; Dambacher J; Tillack C; Sackmann M; Göke B; Lohse P; Ochsenkühn T
    Scand J Gastroenterol; 2006 Dec; 41(12):1421-32. PubMed ID: 17101573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.
    Papp M; Altorjay I; Dotan N; Palatka K; Foldi I; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Norman GL; Szamosi T; Papp J; ; Lakatos PL
    Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined type-1 plasminogen activator inhibitor and NOD2/CARD15 genotyping predicts complicated Crohn's disease behaviour.
    Alvarez-Lobos M; Arostegui JI; Sans M; Tassies D; Piu J; Reverter JC; Pique JM; Yagüe J; Panés J
    Aliment Pharmacol Ther; 2007 Feb; 25(4):429-40. PubMed ID: 17269998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colonic lymphoid follicles and NOD2/CARD15 mutational status in Crohn's disease.
    Nascimbeni R; Villanacci V; Bassotti G; Fisogni S; Gervasi M; Rossi E; Di Lorenzo D
    Br J Surg; 2009 Jun; 96(6):655-62. PubMed ID: 19434699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of allelic heterogeneity for associations between the NOD2/CARD15 gene and ulcerative colitis among North Indians.
    Juyal G; Amre D; Midha V; Sood A; Seidman E; Thelma BK
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1325-32. PubMed ID: 17892524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.